Quality of Life Comparison in Patients With Different Types of Alopecia
RDACCQV
1 other identifier
observational
100
1 country
1
Brief Summary
Hair loss is a frequent cause of patient consultation in dermatology. It is known to have a strong impact on patients' quality of life for many reasons; such as esthetic aspect, financial implications, social consequences. Numerous studies have assessed the impact of some types of alopecia on patients' quality of life. One study compared the quality of life in patients with scarring alopecia with patients of non-scarring alopecia. No studies have compared quality of life between the different types of scarring alopecia nor different types of non-scarring alopecia. However, none have assessed the impact on the patient partner quality of life. In addition, few treatments for alopecia are covered by national health insurance in France. The main objective is to compare the impact on the quality of life in different types of alopecia. By using the average scores of the questionnaire Dermatology Life Quality Index (DLQI) for each type of alopecia.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Mar 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 4, 2019
CompletedFirst Submitted
Initial submission to the registry
January 21, 2020
CompletedFirst Posted
Study publicly available on registry
January 29, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 16, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 16, 2020
CompletedDecember 2, 2020
December 1, 2020
1.7 years
January 21, 2020
December 1, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in patient life
The Dermatology life Quality Index (DLQI) is a ten-question questionnaire used to measure the impact of skin disease on the quality of life of an affected person. It is designed for people aged 16 years and above. There are 10 questions, covering the following topics: symptoms, embarrassment, shopping and home care, clothes, social and leisure, sport, work or study, close relationships, sex, treatment. Each question refers to the impact of the skin disease on the patient's life over the previous week. Each question is scored from 0 to 3, giving a possible score range form 0 (meaning no impact of skin disease on quality of life) to 30 (meaning maximum impact on quality of life).
at day 0
Secondary Outcomes (1)
Variation of score of questionnaire Dermatology Life Quality Index (DLQI) according alopecia type in spouse life
at day 0
Interventions
Every patient will have to fill out a general quality of life questionary : DLQI (Dermatology Life Quality Index)
Every patient will have to fill out a specific quality of life questionary : Hair Specific Skindex 29.
Eligibility Criteria
Every patient consulting in the dermatology department of Amiens' University Hospital for a primary alopecia will have to fill out 2 questionnaires of quality of life: one general (DLQI : Dermatology Life Quality Index) and one specific (Hair Specific Skindex 29). Every patient partner will have to complete one questionnaire of quality of life: FDLQI (Family DLQI).
You may qualify if:
- patients affiliated to social security
- patients able to understand and fill out a questionnaire
- patients over 18 years old
- patient consulting in the dermatology department of Amiens University Hospital for a primary alopecia
You may not qualify if:
- minors
- patients under guardianship, deprived of liberty
- scalp affections other than alopecia
- secondary alopecia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU Amiens
Amiens, 80480, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Catherine LOK, Pr
CHU Amiens
- PRINCIPAL INVESTIGATOR
Thomas Baltazard, MD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Nesrine Zitouni, MD
CHU Amiens
- PRINCIPAL INVESTIGATOR
Fanny Dessirier, MD
CHU Amiens
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 21, 2020
First Posted
January 29, 2020
Study Start
March 4, 2019
Primary Completion
November 16, 2020
Study Completion
November 16, 2020
Last Updated
December 2, 2020
Record last verified: 2020-12
Data Sharing
- IPD Sharing
- Will not share